Target Health Resources

Abstract

Society of Investigative Dermatology: Deep Dermal Burns

May 4, 2005

,
CRO
|
Abstract

Global, internet-based clinical trials (G-IBCTs) can offer convenient, cost-effective solutions for the streamlining aspects of the clinical research process.

Clinical Pharmacology and Therapeutics: Pediatric Web Trial

March 2, 2005

,
CRO
|
Abstract

The rationale for the use of an internet-based clinical trial to obtain safety, pharmacokinetic and pharmacodynamic data in dose escalation study in neonates, with hyperbilirubinemia, who need exchange transfusion.

American Academy of Dermatology: Global Clinical Trial

February 18, 2005

,
CRO
|
Abstract

Global, internet-based clinical trials (G-IBCTs) can offer convenient, cost-effective solutions for the streamlining aspects of the clinical research process.

American Academy of Dermatology: Evaluating Oral Drugs

March 21, 2003

,
CRO
|
Abstract

Dermatology provides an unmet need for drug development. There are two reasons to develop drugs for topical use. The first is to treat skin diseases and disorders such as psoriasis, acne, actinic keratosis, cancer, eczema, etc. These conditions represent some of the most common and chronic disease states in man. The second reason is to deliver systemically active drugs through the skin to enhance drug activity by, 1. avoiding first pass metabolism, 2. reducing toxicity and 3. improving compliance.

The Effects of L-Arginine and Yohimbine on Sexual Arousal

August 31, 2002

,
CRO
|
Abstract

The present study was designed to determine the effects of oral administration of the nitric oxide-precursor Larginine, in combination with the alpha2 blocker yohimbine, on subjective and physiological (vaginal photoplethysmography) responses to erotic stimuli in postmenopausal women with Female Sexual Arousal Disorder (FSAD).

Vasomax for the Treatment of Male Erectile Dysfunction

February 19, 2001

,
CRO
|
Abstract

This paper reviews laboratory and clinical data concerning oral phentolamine mesylate, Vasomax, an alpha-1, alpha-2 adrenergic receptor antagonist developed specifically for treatment of erectile dysfunction.

Contact Target Health

Reach out today and let us know how we can help you!
Phone: 212-681-2100
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form